TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Clinical trials for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood disorder: drug cocktail aims to restore blood cell production
Disease control Not yet recruitingThis study tests a combination of three drugs (cyclosporine, eltrombopag or hetrombopag, and romiplostim) in 43 adults newly diagnosed with severe aplastic anemia, a condition where the bone marrow fails to produce enough blood cells. The goal is to see if this treatment can help…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New hope for anemia patients: drug combo may reduce need for blood transfusions
Disease control Not yet recruitingThis study tests whether adding enarodustat to standard cyclosporine treatment works better than cyclosporine alone for people newly diagnosed with a type of aplastic anemia that requires regular blood transfusions. About 90 adults who cannot have a stem cell transplant will take…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 17, 2026 04:10 UTC
-
New drug cocktail aims to free aplastic anemia patients from transfusions
Disease control Not yet recruitingThis study tests a combination of three drugs (cyclosporine, eltrombopag or hetrombopag, and romiplostim) in adults newly diagnosed with severe aplastic anemia or transfusion-dependent non-severe aplastic anemia. The goal is to see if this treatment can improve blood cell counts …
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 17, 2026 04:09 UTC
-
New combo therapy aims to free patients from blood transfusions
Disease control Not yet recruitingThis study tests whether adding enarodustat to standard cyclosporine treatment helps people with a type of aplastic anemia that needs regular blood transfusions. About 90 adults will receive either the drug combo or cyclosporine alone. The goal is to see if the combination improv…
Matched conditions: TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 15, 2026 11:54 UTC